768 related articles for article (PubMed ID: 28399931)
1. Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
Kimura Y; Grevich S; Beukelman T; Morgan E; Nigrovic PA; Mieszkalski K; Graham TB; Ibarra M; Ilowite N; Klein-Gitelman M; Onel K; Prahalad S; Punaro M; Ringold S; Toib D; Van Mater H; Weiss JE; Weiss PF; Schanberg LE;
Pediatr Rheumatol Online J; 2017 Apr; 15(1):23. PubMed ID: 28399931
[TBL] [Abstract][Full Text] [Related]
2. Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).
Nigrovic PA; Beukelman T; Tomlinson G; Feldman BM; Schanberg LE; Kimura Y;
Clin Trials; 2018 Jun; 15(3):268-277. PubMed ID: 29542334
[TBL] [Abstract][Full Text] [Related]
3. First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.
Beukelman T; Tomlinson G; Nigrovic PA; Dennos A; Del Gaizo V; Jelinek M; Riordan ME; Schanberg LE; Mohan S; Pfeifer E; Kimura Y;
Pediatr Rheumatol Online J; 2022 Dec; 20(1):113. PubMed ID: 36482434
[TBL] [Abstract][Full Text] [Related]
4. The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months.
Beukelman T; Kimura Y; Ilowite NT; Mieszkalski K; Natter MD; Burrell G; Best B; Jones J; Schanberg LE;
Pediatr Rheumatol Online J; 2017 Apr; 15(1):30. PubMed ID: 28416023
[TBL] [Abstract][Full Text] [Related]
5. Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey.
Shenoi S; Nanda K; Schulert GS; Bohnsack JF; Cooper AM; Edghill B; Gillispie-Taylor MC; Goldberg B; Halyabar O; Mason TG; Ronis T; Schneider R; Vehe RK; Onel K;
Pediatr Rheumatol Online J; 2019 Jul; 17(1):48. PubMed ID: 31331351
[TBL] [Abstract][Full Text] [Related]
6. Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis.
DeWitt EM; Kimura Y; Beukelman T; Nigrovic PA; Onel K; Prahalad S; Schneider R; Stoll ML; Angeles-Han S; Milojevic D; Schikler KN; Vehe RK; Weiss JE; Weiss P; Ilowite NT; Wallace CA;
Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1001-10. PubMed ID: 22290637
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.
Kimura Y; Schanberg LE; Tomlinson GA; Riordan ME; Dennos AC; Del Gaizo V; Murphy KL; Weiss PF; Natter MD; Feldman BM; Ringold S;
Arthritis Rheumatol; 2021 Oct; 73(10):1898-1909. PubMed ID: 34105312
[TBL] [Abstract][Full Text] [Related]
8. Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry.
Horneff G; Schulz AC; Klotsche J; Hospach A; Minden K; Foeldvari I; Trauzeddel R; Ganser G; Weller-Heinemann F; Haas JP
Arthritis Res Ther; 2017 Nov; 19(1):256. PubMed ID: 29166924
[TBL] [Abstract][Full Text] [Related]
9. Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis.
Cooper JC; Rouster-Stevens K; Wright TB; Hsu JJ; Klein-Gitelman MS; Ardoin SP; Schanberg LE; Brunner HI; Eberhard BA; Wagner-Weiner L; Mehta J; Haines K; McCurdy DK; Phillips TA; Huang Z; von Scheven E;
Pediatr Rheumatol Online J; 2018 Oct; 16(1):65. PubMed ID: 30348175
[TBL] [Abstract][Full Text] [Related]
10. Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry.
Beukelman T; Ringold S; Davis TE; DeWitt EM; Pelajo CF; Weiss PF; Kimura Y;
J Rheumatol; 2012 Sep; 39(9):1867-74. PubMed ID: 22859354
[TBL] [Abstract][Full Text] [Related]
11. Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior Uveitis.
Angeles-Han ST; Lo MS; Henderson LA; Lerman MA; Abramson L; Cooper AM; Parsa MF; Zemel LS; Ronis T; Beukelman T; Cox E; Sen HN; Holland GN; Brunner HI; Lasky A; Rabinovich CE;
Arthritis Care Res (Hoboken); 2019 Apr; 71(4):482-491. PubMed ID: 29806733
[TBL] [Abstract][Full Text] [Related]
12. Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.
Li SC; Fuhlbrigge RC; Laxer RM; Pope E; Ibarra MF; Stewart K; Mason T; Becker ML; Hong S; Dedeoglu F; Torok KS; Rabinovich CE; Ferguson PJ; Punaro M; Feldman BM; Andrews T; Higgins GC;
Pediatr Rheumatol Online J; 2019 Jul; 17(1):43. PubMed ID: 31307476
[TBL] [Abstract][Full Text] [Related]
13. Pilot Study of the Juvenile Dermatomyositis Consensus Treatment Plans: A CARRA Registry Study.
Liu K; Tomlinson G; Reed AM; Huber AM; Saarela O; Bout-Tabaku SM; Curran M; Dvergsten JA; Eberhard BA; Jung LK; Kim S; Ringold S; Rouster-Steven KA; Tesher M; Wahezi DM; Feldman BM;
J Rheumatol; 2021 Jan; 48(1):114-122. PubMed ID: 32238513
[TBL] [Abstract][Full Text] [Related]
14. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.
Spencer CH; Rouster-Stevens K; Gewanter H; Syverson G; Modica R; Schmidt K; Emery H; Wallace C; Grevich S; Nanda K; Zhao YD; Shenoi S; Tarvin S; Hong S; Lindsley C; Weiss JE; Passo M; Ede K; Brown A; Ardalan K; Bernal W; Stoll ML; Lang B; Carrasco R; Agaiar C; Feller L; Bukulmez H; Vehe R; Kim H; Schmeling H; Gerstbacher D; Hoeltzel M; Eberhard B; Sundel R; Kim S; Huber AM; Patwardhan A;
Pediatr Rheumatol Online J; 2017 Jun; 15(1):50. PubMed ID: 28610606
[TBL] [Abstract][Full Text] [Related]
15. The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013.
Janow G; Schanberg LE; Setoguchi S; Hasselblad V; Mellins ED; Schneider R; Kimura Y;
J Rheumatol; 2016 Sep; 43(9):1755-62. PubMed ID: 27307527
[TBL] [Abstract][Full Text] [Related]
16. Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis.
Ringold S; Weiss PF; Colbert RA; DeWitt EM; Lee T; Onel K; Prahalad S; Schneider R; Shenoi S; Vehe RK; Kimura Y;
Arthritis Care Res (Hoboken); 2014 Jul; 66(7):1063-72. PubMed ID: 24339215
[TBL] [Abstract][Full Text] [Related]
17. Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance.
Sherman MA; Kim H; Banschbach K; Brown A; Gewanter HL; Lang B; Perron M; Robinson AB; Spitznagle J; Stingl C; Syverson G; Tory HO; Spencer CH; Tarvin SE
Pediatr Rheumatol Online J; 2023 Jan; 21(1):3. PubMed ID: 36609397
[TBL] [Abstract][Full Text] [Related]
18. Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.
Beukelman T; Lougee A; Matsouaka RA; Collier D; Rumsey DG; Schenfeld J; Stryker S; Twilt M; Kimura Y;
Pediatr Rheumatol Online J; 2021 Aug; 19(1):131. PubMed ID: 34419107
[TBL] [Abstract][Full Text] [Related]
19. Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
Horton DB; Onel KB; Beukelman T; Ringold S
J Rheumatol; 2017 Mar; 44(3):352-360. PubMed ID: 28148696
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
